In lymphocytes, CD8+CCR7+ expressing cells of BDA patients (8.87 ± 6.26%, p = 0.04) were significantly higher than those of RA patients (5.42 ± 3.21%) (Figure 2L). This evidence concerns the gene CD8A and rheumatoid arthritis.